Skip to main content
Log in

Vorsorge gastrointestinaler Tumoren

Präventionsmaßnahmen unter Einschluss der Koloskopie

Prevention of gastrointestinal tumors

Screening measures including colonoscopy

  • CME Zertifizierte Fortbildung
  • Published:
Der Gastroenterologe Aims and scope

Zusammenfassung

Die frühzeitige Diagnose eines gastrointestinalen Tumors kann zu einer Reduktion der Mortalität und zu einer Verbesserung der Prognose führen. Die Effektivität der Screeningprogramme ist für das kolorektale Karzinom belegt. Entsprechende Algorithmen haben sich durchgesetzt. Bei anderen Tumoren bleibt die abschließende Beurteilung von Screeningmaßnahmen z. T. unbeantwortet. Inzidenz der Erkrankung, Kosten der Maßnahmen und das Risiko einer sog. Überdiagnose müssen dabei gegeneinander abgewogen werden.

Abstract

Early diagnosis of gastrointestinal tumors may lead to a reduction in mortality and to improved prognosis. The effectiveness of screening programs for colorectal cancer has been proven. Corresponding algorithms have prevailed. For other tumors the final judgment of screening programs remains mainly unanswered. The incidence of the disease, costs of screening and the risk of overdiagnosis still need to be evaluated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3

Literatur

  1. Adler A, Wegscheider K, Lieberman D et al (2012) Factors determining the quality of screening colonoscopy: a prospective study on adenomadetection rates, from 12,134 examinations (Berlin colonoscopy project 3, BECOP-3). Gut (Epub ahead of print)

  2. Brenner H, Altenhofen L, Katalinic A et al (2011) Sojourn time of preclinical colorectal cancer by sex and age: estimates from the German national screening colonoscopy database. Am J Epidemiol 174: 1140–1146

    Article  PubMed  Google Scholar 

  3. Cao Q, Ran ZH, Xiao SD (2007) Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies. J Dig Dis 8: 15–22

    Article  PubMed  CAS  Google Scholar 

  4. Diamond SJ, Enestvedt BK, Jiang Z et al (2011) Adenoma detection rate increases with each decade of life after 50 years of age Gastroint Endosc 74: 135–140

  5. Fietkau R, Zettl H, Klöcking S, Kundt G (2004) Incidence, therapy and prognosis of colorectal cancer in different age groups. A population-based cohort study of the Rostock Cancer Registry. Strahlenther Onkol 180: 478–487

    PubMed  Google Scholar 

  6. Hoffmeister M, Haug U, Brenner H (2009) Screening: prerequisites. Internist 49: 655–659

    Article  Google Scholar 

  7. Hvid-Jensen F, Pedersen L, Drewes AM et al (2011) Incidence of adenocarcinoma among patients with Barrett’s esophagus. N Engl J Med 365: 1375–1383

    Article  PubMed  CAS  Google Scholar 

  8. Jorgensen OD, Kronborg O, Fenger C (2002) A randomized study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds. Gut 50: 29–32

    Article  PubMed  CAS  Google Scholar 

  9. Kewenter J, Brevinge H, Engarås B et al (1994) Results of screening, rescreening and follow-up in a prospective randomized study for detection of colorectal cancer by fecal-occult-blood testing. Results for 68,308 subjects. Scand J Gastroenterol 29: 468–473

    Article  PubMed  CAS  Google Scholar 

  10. Kumon RE, Repaka A, Atkinson M et al (2012) Characterization of the pancreas in vivo using EUS spectrum analysis with electronic array echoendoscopes. Gastrointest Endosc 75: 1175–1183

    Article  PubMed  Google Scholar 

  11. Mandel JS, Bond JH, Church TR et al (1993) Reducing mortality from colorectal cancer by screening for faecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 328: 1365–1371

    Article  PubMed  CAS  Google Scholar 

  12. Pickhardt PJ, Choi JR, Hwang I et al (2003) Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N Engl J Med 349: 2191–2200

    Article  PubMed  CAS  Google Scholar 

  13. Quintero E, Castells A, Bujanda L et al (2012) Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med 366: 697–706

    Article  PubMed  CAS  Google Scholar 

  14. Raimondi S, Lowenfels AB, Morselli-Labate AM et al (2010) Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detection. Best Pract Res Clin Gastroenterol 24: 349–358

    Article  PubMed  Google Scholar 

  15. Riemann JF, Maar C, Betzler M et al (2011) Early detection of colonic cancer in the National Cancer Program–present status and recommendations Z Gastroenterol 49: 1428–1431

  16. Sarkar M, Stewart S, Yu A et al (2012) Hepatocellular carcinoma screening practices and impact on survival among hepatitis B-infected Asian Americans. J Viral Hepat 19: 594–600

    Article  PubMed  CAS  Google Scholar 

  17. Schneider R, Slater EP, Sina M et al (2011) German national case collection for familial pancreatic cancer (FaPaCa): ten years experience. Fam Cancer 10: 323–330

    Article  PubMed  Google Scholar 

  18. Sieg A, Theilmeier A (2006) Ergebnisse der Vorsorge-Koloskopie 2005. Dtsch Med Wochenschr 131: 379-383

    Article  PubMed  CAS  Google Scholar 

  19. Spada C, Hassan C, Galmiche JP et al (2012) Colon capsule endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 44: 527–536

    Article  PubMed  CAS  Google Scholar 

  20. Uemura N, Okamoto S, Yamamoto S et al (2001) Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345: 784–789

    Article  PubMed  CAS  Google Scholar 

  21. Van Rossum LG, van Rijn AF, Laheij RJ et al (2008) Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 135: 82–90

    Article  Google Scholar 

  22. Warren J, Xiong W, Bunker A et al (2011) Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer BMC 14: 129–133

  23. Watabe H, Mitsushima T, Yamaji Y et al (2005) Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study. Gut 54: 764–768

    Article  PubMed  CAS  Google Scholar 

  24. Winawer SJ, Zauber AG, Ho MN et al (1993) Reduction of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 29: 1977–1981

    Article  Google Scholar 

  25. Zauber AG, Winawer SJ, O’Brien MJ et al (2012) Polypectomy and long-term prevention of colorectal-cancer deaths N Engl J Med 366: 687–696

  26. Zhang BH, Yang BH, Tang ZY (2004) Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol 130: 417–421

    PubMed  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt für sich und seine Koautoren an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to U. Damian.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Damian, U., Schilling, D. & Riemann, J. Vorsorge gastrointestinaler Tumoren. Gastroenterologe 7, 531–540 (2012). https://doi.org/10.1007/s11377-012-0704-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11377-012-0704-8

Schlüsselwörter

Keywords

Navigation